PL3603621T3 - Liposomy do leczenia chorób oczu - Google Patents

Liposomy do leczenia chorób oczu

Info

Publication number
PL3603621T3
PL3603621T3 PL19189078.9T PL19189078T PL3603621T3 PL 3603621 T3 PL3603621 T3 PL 3603621T3 PL 19189078 T PL19189078 T PL 19189078T PL 3603621 T3 PL3603621 T3 PL 3603621T3
Authority
PL
Poland
Prior art keywords
liposomes
treatment
ocular diseases
ocular
diseases
Prior art date
Application number
PL19189078.9T
Other languages
English (en)
Inventor
Ana Laura LÓPEZ MACHADO
Elena SÁNCHEZ LÓPEZ
Maria Luisa GARCIA LOPEZ
Martina BIANCARDI
Original Assignee
Tdc Technology Dedicated To Care S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tdc Technology Dedicated To Care S.R.L. filed Critical Tdc Technology Dedicated To Care S.R.L.
Publication of PL3603621T3 publication Critical patent/PL3603621T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1276—Globules of milk; Constituents thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL19189078.9T 2018-07-31 2019-07-30 Liposomy do leczenia chorób oczu PL3603621T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102018000007677A IT201800007677A1 (it) 2018-07-31 2018-07-31 Liposomi per il trattamento di patologie oculari

Publications (1)

Publication Number Publication Date
PL3603621T3 true PL3603621T3 (pl) 2025-06-16

Family

ID=63965859

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19189078.9T PL3603621T3 (pl) 2018-07-31 2019-07-30 Liposomy do leczenia chorób oczu

Country Status (6)

Country Link
US (1) US10835494B2 (pl)
EP (1) EP3603621B1 (pl)
ES (1) ES3024689T3 (pl)
IT (1) IT201800007677A1 (pl)
PL (1) PL3603621T3 (pl)
PT (1) PT3603621T (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230190652A1 (en) 2020-04-16 2023-06-22 Dermopartners,S.L. Composition for the treatment of covid-19 and treatment method
IT202000009430A1 (it) 2020-04-29 2021-10-29 Tdc Tech Dedicated To Care Srl Composizione per la prevenzione e/o il trattamento delle infezioni delle vie respiratorie
US11833224B1 (en) 2023-02-08 2023-12-05 Leuvian Llc Lyoprotectant compositions and uses thereof
CN121532204A (zh) * 2023-02-22 2026-02-13 莱克蒂亚治疗有限公司 纯化的乳铁蛋白组合物和使用方法
IT202300024966A1 (it) * 2023-11-23 2025-05-23 Offhealth Spa Collirio a base di liposomi di lattoferrina con vit. e tpgs e stearilamina, per il trattamento di malattie oculari

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2284398B2 (es) * 2006-04-27 2008-12-16 Universidad Complutense De Madrid Formulacion de vesiculas liposomales en soluciones acuosas con caracteristicas de pelicula lagrimal.
US20120003296A1 (en) * 2010-07-01 2012-01-05 Shantha Totada R New methods of treating dry eye syndrome

Also Published As

Publication number Publication date
PT3603621T (pt) 2025-05-14
US20200046641A1 (en) 2020-02-13
EP3603621B1 (en) 2025-02-19
IT201800007677A1 (it) 2020-01-31
EP3603621A1 (en) 2020-02-05
ES3024689T3 (en) 2025-06-05
US10835494B2 (en) 2020-11-17

Similar Documents

Publication Publication Date Title
IL276383B1 (en) Treatment of ophthalmological diseases
IL277333A (en) Methods for treating eye diseases
IL278178A (en) Use of pilocarpine hydrochloride to treat eye disorder
IL289405A (en) Personalized treatment of eye diseases
IL287280A (en) Compounds and methods for the treatment of ocular disorders
PT3603621T (pt) Lipossomas para o tratamento de doenças oculares
IL268357A (en) Photoreceptor cells for the treatment of retinal diseases
GB201804514D0 (en) Treatment of pyroptosis
SG11202006374VA (en) Treatment of demyelinating diseases
ZA202006234B (en) Compositions and methods for the treatment of neurological diseases
IL282643A (en) Soft combinations for the treatment of hematological diseases
IL282361A (en) Treatment for neurological diseases
GB201805100D0 (en) Treatment of sarcopenic diseases
IL287264A (en) Compounds and methods for the treatment of ocular disorders
EP3675889A4 (en) ANGIO-3 FOR THE TREATMENT OF RETINAL ANGIOGENIC DISEASES
PL3761982T3 (pl) Zastosowanie nalfurafiny w leczeniu chorób demielinizacyjnych
PT3619204T (pt) Compostos para o tratamento de doenças respiratórias
PL3407879T3 (pl) Gabapentyna okulistyczna do leczenia wrzodów rogówki
GB201914516D0 (en) Treatment of eye disease
IL263837A (en) Treatment of ocular disease
GB2603379B (en) Avocatin B for the treatment of diseases and conditions
GB201909438D0 (en) Treatment of diseases
HK40061035A (en) Novel compounds for the treatment of respiratory diseases
HK40059587A (en) Combination therapy for treatment of hematological diseases
AU2018904241A0 (en) Novel compounds for the treatment of respiratory diseases